Invitae Corp. has announced it has raised $120 million in series F financing.

Invitae, based in San Francisco, is a genetic information company specializing in genetic diagnostics for hereditary disorders.

New investors participating in the round included The Broe Group, Decheng Capital, Deerfield Management, OrbiMed, Perceptive Advisors, Rock Springs Capital and Wellington Management Company. Existing investors participating in the financing included Casdin Capital, Genesys Capital, Genomic Health, Randy Scott, Redmile Group and Thomas McNerney & Partners.

Invitae indicated that it planned to use proceeds from the financing round to accelerate the build out of its infrastructure for its genetic information business and expand its global presence.